Bio Protocol vs FUNToken — how do they compare? Bio Protocol trades at Rp442.2 (market cap Rp1,01T, Rp174,27M 24h volume), while FUNToken trades at Rp0 (market cap Rp80,89M, Rp46,64M 24h volume). The key difference: Bio Protocol is far larger — about 12486.1× FUNToken's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while FUNToken's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and FUNToken for 19 Days on average.
| BIO | FUN | |
|---|---|---|
Market Cap | Rp1,01T | Rp80,89M |
Volume (24h) | Rp174,27M | Rp46,64M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 10,8B FUN |
Typical Hold Time | 17 Days | 19 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
FUNToken shows limited market activity with a modest market cap of Rp80.89M and circulating supply of 10.8M tokens. The token exhibits low trading volume and network activity, with an average hold time of 19 days suggesting short-term speculative interest. No recent protocol upgrades or significant ecosystem developments were identified in available crypto sources.
Outlook remains cautious due to minimal trading activity and lack of fundamental catalysts. Key risk is low liquidity and market depth. Opportunity exists if the project gains developer traction or exchange listings, but current metrics suggest limited investor interest in the token ecosystem.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →FUNToken is a blockchain asset that powers secure, low-cost gaming and DeFi transactions, giving users full control of their assets across a wide entertainment ecosystem.
Read more on FUN →